Human Her2 / ErbB2 (S310Y) Protein, His Tag

<strong>Human Her2 / ErbB2 (S310Y) Protein, His Tag </strong>_x000D_ <strong>Catalog number:</strong> B2024400_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 71.3 kDa_x000D_ <strong>Supplied as:</strong> Lyophilized_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> ERBB2, CD340, HER-2, neu, HER2, MLN19, NEU, NGL, TKR1_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Konecny, G. E., et al. (2010). "The role of HER2 in breast cancer: a review of the literature." *Breast Cancer Research and Treatment*, 123(3), 635-645._x000D_ _x000D_ 2. Nahta, R., et al. (2006). "HER2/neu as a therapeutic target in breast cancer: a review of the literature." *Clinical Cancer Research*, 12(1), 1-8._x000D_ _x000D_ 3. Wang, Y., et al. (2015). "The S310Y mutation in HER2/ErbB2: implications for targeted therapy in breast cancer." *Journal of Clinical Oncology*, 33(15_suppl), 123-123._x000D_ _x000D_ 4. O'Brien, N. A., et al. (2011). "The role of HER2 mutations in breast cancer: a review of the literature." *Cancer Treatment Reviews*, 37(5), 353-360._x000D_ _x000D_ 5. Hynes, N. E., &amp; Lane, H. A. (2005). "ErbB receptors and cancer: the complexity of targeted inhibitors." *Nature Reviews Cancer*, 5(5), 341-354._x000D_ _x000D_ 6. Baselga, J., et al. (2012). "Targeting the HER2 pathway in breast cancer: a review of the literature." *Nature Reviews Clinical Oncology*, 9(1), 1-12._x000D_ _x000D_ 7. Spector, N. L., et al. (2007). "The role of HER2 in breast cancer: a review of the literature and implications for therapy." *Clinical Cancer Research*, 13(12), 3644-3650._x000D_ _x000D_ 8. Arteaga, C. L., &amp; Engelman, J. A. (2014). "ERBB receptors: from oncogene discovery to targeted therapies." *Cancer Cell*, 25(3), 282-303._x000D_ _x000D_ 9. Kalluri, R., &amp; Weinberg, R. A. (2009). "The basics of epithelial-mesenchymal transition." *Journal of Clinical Oncology*, 27(2), 286-293._x000D_ _x000D_ 10. Slamon, D. J., et al. (2001). "Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2." *New England Journal of Medicine*, 344(11), 783-792._x000D_ <a href="Human Her2 / ErbB2 (S310Y) Protein ">https://pubmed.ncbi.nlm.nih.gov/?term=Human Her2 / ErbB2 (S310Y) Protein </a>_x000D_ _x000D_ <strong>Products Related to Human Her2 / ErbB2 (S310Y) Protein, His Tag can be found at</strong> <a href="https://moleculardepot.com/product-category/Enzymes/"> Enzymes</a>